New Delhi: From 2023 to 2033, the market for orthopaedic devices is anticipated to grow at a CAGR of 4%. The market is currently estimated to be worth US$ 45 billion, and by the end of 2033, it is predicted to be worth US$ 67 billion.
The demand for joint reconstruction devices is primarily being driven by an increase in joint replacement and pain management procedures, as well as a rise in the prevalence of joint pain and damaged joints among the elderly population.
The recent adoption of cutting-edge ideas like wearable medical technology and medical fabrics has undoubtedly changed orthopaedics. Joint replacement procedures’ component parts have already undergone a significant effort to modularize in order to create a system that offers more individualised care.
The ability to market gender-specific components, the potential to address long-term biomechanical alignment issues, and individually sized hip cups and balls based on the patient’s needs and capacity are just a few of the development-related issues that recent orthopaedic device advancements are addressing. Over the projection period, it is anticipated that, in addition to the standard joint replacements like hip and knee replacements, evolutionary growth and system growth related to alignment tools and robotic surgery will increase.
The presence of leading orthopaedic device producers, a strong healthcare system, and benevolent reimbursement policies are expected to drive market expansion in the US. A rise in road accidents and a high demand for modern healthcare services are raising the country’s market value.
Increased market growth is anticipated as a result of the high prevalence of orthopaedic diseases, rising R&D expenditures, and widespread application of cutting-edge therapeutic approaches.
Competitive Landscape
Key orthopedic device suppliers with technical expertise and core competencies are making consistent efforts to manufacture novel orthopedic products and maintain quality control following safety regulations to reduce the environmental impact to attract more customers. Some examples of these are orthopedic medical devices and orthopedic fixation devices.
Improved biomaterial-based implants offering high strength and low wear are witnessing an exponential increase in demand across developed and developing countries. Several leading companies are collaborating with emerging market entrants, enhancing product standards, and focusing on supply chain management.
For instance,
-
Johnson and Johnson collaborated with Aspect Bio systems, a company engaged in 3D bio printing and tissue engineering to launch new and advanced orthopedic devices.
